Rothschild Asset Management Inc. grew its holdings in Johnson & Johnson (NYSE:JNJ) by 33.8% during the third quarter, Holdings Channel reports. The fund owned 440,656 shares of the company’s stock after purchasing an additional 111,323 shares during the period. Rothschild Asset Management Inc.’s holdings in Johnson & Johnson were worth $57,290,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also added to or reduced their stakes in JNJ. Harding Loevner LP acquired a new stake in shares of Johnson & Johnson in the 2nd quarter valued at about $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in shares of Johnson & Johnson by 29.9% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after purchasing an additional 200 shares during the period. Mountain Capital Investment Advisors Inc acquired a new stake in shares of Johnson & Johnson in the 2nd quarter valued at about $124,000. Shine Investment Advisory Services Inc. acquired a new stake in shares of Johnson & Johnson in the 2nd quarter valued at about $177,000. Finally, Lenox Wealth Management Inc. boosted its position in shares of Johnson & Johnson by 1.7% in the 2nd quarter. Lenox Wealth Management Inc. now owns 1,457 shares of the company’s stock valued at $193,000 after purchasing an additional 24 shares during the period. Institutional investors and hedge funds own 65.58% of the company’s stock.
A number of brokerages recently issued reports on JNJ. JPMorgan Chase & Co. cut Johnson & Johnson from an “overweight” rating to a “neutral” rating in a research report on Tuesday, January 2nd. Vetr raised Johnson & Johnson from a “hold” rating to a “buy” rating and set a $147.14 price objective for the company in a research report on Wednesday, December 20th. BMO Capital Markets increased their price objective on Johnson & Johnson to $161.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 12th. BTIG Research reaffirmed a “sell” rating and set a $110.00 price objective on shares of Johnson & Johnson in a research report on Wednesday, January 24th. Finally, Zacks Investment Research cut Johnson & Johnson from a “buy” rating to a “hold” rating in a research report on Tuesday, December 12th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $146.16.
Johnson & Johnson (JNJ) opened at $129.91 on Thursday. The stock has a market capitalization of $349,010.00, a P/E ratio of 333.10, a PEG ratio of 2.23 and a beta of 0.74. Johnson & Johnson has a one year low of $119.25 and a one year high of $148.32. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.02 and a current ratio of 1.32.
Johnson & Johnson (NYSE:JNJ) last issued its earnings results on Tuesday, January 23rd. The company reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.02. The business had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.08 billion. Johnson & Johnson had a return on equity of 27.80% and a net margin of 1.70%. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.58 EPS. research analysts anticipate that Johnson & Johnson will post 8.11 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Stockholders of record on Tuesday, February 27th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date is Monday, February 26th. Johnson & Johnson’s dividend payout ratio (DPR) is 861.54%.
ILLEGAL ACTIVITY NOTICE: “Johnson & Johnson (JNJ) Stake Lifted by Rothschild Asset Management Inc.” was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.chaffeybreeze.com/2018/02/22/johnson-johnson-jnj-stake-lifted-by-rothschild-asset-management-inc.html.
Johnson & Johnson Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.